Evidence map›Paper›PMID 32454666›Full record

ArticleTurkish journal of pharmaceutical sciences2018

Biofabrication of Copper Nanoparticles: A Next-generation Antibacterial Agent Against Wound-associated Pathogens.

Pallavi Singh Chauhan, Vikas Shrivastava, Rajesh Singh Tomar

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of pharmaceutical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Metal-organic framework-modulated FeJournal of nanobiotechnology · 2023
    Article
  3. Potential Production of Theranostic Boron Nitride Nanotubes (Nanomaterials (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Pallavi Singh ChauhanAmity University, Amity Institute of Biotechnology, Madhya Pradesh, India.ORCID https://orcid.org/0000-0003-1341-7393
Vikas ShrivastavaAmity University, Amity Institute of Biotechnology, Madhya Pradesh, India.ORCID https://orcid.org/0000-0001-5838-3129
Rajesh Singh TomarAmity University, Amity Institute of Biotechnology, Madhya Pradesh, India.ORCID https://orcid.org/0000-0002-2412-5145

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesImpaired wound healing is a major complication. A few factors such as blood glucose level, poor circulation, immune system deficiency, and infection are the root causes of impaired wound healing. The aim of the present study was to bio-synthesize copper nanoparticles with potential antibacterial activity against wound-associated pathogens. MATERIALS AND

methodsCopper nanoparticles were fabricated using the sol-gel method with the mixing of

resultsThe results obtained from TEM, SEM, and XRD characterization showed that the particle size was below 100 nm and of spherical shape. FTIR analysis showed the possibility of various biomolecules, which have a role in capping and stabilizing copper nanoparticles. The particles synthesized showed antibacterial activity against four wound-associated pathogens

conclusionThe biosynthesized copper nanoparticles showed potent antimicrobial activity, thus the antibacterial activity of the synthesized copper nanoparticles could be used in several biomedical applications. Additionally, they can be exploited as a better therapeutic agent for treating infection seen in impaired diabetic wounds. The particles synthesized by the biological route are eco-friendly, less toxic, feasible, and cost effective.

Indexed as

biomedical applicationsbiosynthesischaracterizationNanoparticlessol-gel processwound-associated pathogens

Identifiers

PMID32454666
PMCPMC7227830
OpenAlexW2805455378

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.